Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phorbol ester for shortening post-chemotherapy myelosuppression in hematological diseases
ChiCTR2100050523Phase 3Recruiting
- Sponsor
- The Peoples' Hospital of Jiaozuo City
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of 12-o-tetradecanoylphorbol-13-acetate in Hematopathy (2 arms), sponsored by The Peoples' Hospital of Jiaozuo City. Primary endpoints: Cytokine levels, Lymphocyte subsets and 5 more. Started Sep 2021; status: recruiting.
02
Drugs
12-o-tetradecanoylphorbol-13-acetate
03
Conditions
Hematopathy
Beyond the preview
Go deeper on ChiCTR2100050523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050523.